Gastric cancer (GC) remains a primary global concern, particularly among men and in East Asian populations, as highlighted in a recent study from Cancer Biology & Medicine. Data from the GLOBOCAN 2022 database indicate approximately 968,000 new GC diagnoses and 660,000 related deaths in 2022, with East Asia shouldering the most significant share: 53.8% of cases and 48.2% of deaths.
Interestingly, the age-standardized incidence and mortality rates (ASIR and ASMR) for cervical cancer also show a strong link to the Human Development Index (HDI), underscoring the relevance of socioeconomic factors. While overall incidence rates declined between 2003 and 2017, a disturbing upswing in cases among younger individuals—especially women—has emerged in Europe, Oceania, and the Americas. Between 2008 and 2012, incidence rates peaked in countries such as New Zealand, Turkey, and South Africa.
Commenting on the alarming increase in early-onset gastric cancer, Wanqing Chen, MD, refers to it as a “global health crisis” demanding swift action. Targeted preventive measures for younger populations should be at the forefront, including enhanced early detection, broader educational campaigns on nutrition, minimized exposure to risk factors such as smoking and H. pylori infection, and strategies to mitigate genetic and epigenetic influences.
Boosting awareness and adapting healthcare systems to identify better and manage early-stage cervical cancer are also essential steps to halt this rising trend. Both local and international initiatives must work toward lowering the incidence and mortality of gastric cancer, with a particular focus on communities most at risk.
Important! The statistical information in medical articles reflects general patterns and does not consider individual factors. Personal circumstances may vary substantially. Always seek professional medical advice for health-related decisions.
